Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1996 Mar;41(3):614-20.
doi: 10.1007/BF02282350.

Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis

Affiliations
Review

Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis

C R Mantyh et al. Dig Dis Sci. 1996 Mar.

Abstract

Pseudomembranous colitis is most often caused by toxins secreted by Clostridium difficile following bowel flora overgrowth after antibiotic use. The secretory and inflammatory effects observed in C. difficile toxin A-induced enterocolitis in the rat ileum are inhibited by CP-96,345, a substance P (SP) receptor antagonist. To determine if SP plays a role in the pathogenesis of human pseudomembranous colitis, SP receptor distribution was examined in a toxin A-positive specimen of bowel. Quantitative receptor autoradiography was used to examine SP receptors in tissue from a patient who tested positive for C. Difficile toxin. SP receptors were massively increased in small blood vessels and lymphoid aggregates in the pseudomembranous colitis bowel in comparison to control specimens. The SP binding was saturable and exhibited similar affinities for SP and CP-96,345. SP may contribute to the inflammatory response in pseudomembranous colitis via a massive increase in SP receptor antagonists may offer a novel therapeutic intervention for pseudomembranous colitis.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Regul Pept. 1993 Jul 2;46(1-2):223-4 - PubMed
    1. J Immunol. 1985 Aug;135(2):1331-7 - PubMed
    1. Gastroenterology. 1995 Sep;109(3):850-60 - PubMed
    1. N Engl J Med. 1994 Jan 27;330(4):257-62 - PubMed
    1. N Engl J Med. 1978 Mar 9;298(10):531-4 - PubMed

Publication types

Substances

LinkOut - more resources